Form 4: Adverum Biotechnologies Director Acquires Stock Options

Patrick Machado, a director at Adverum Biotechnologies, acquired stock options on June 17, 2024, according to a Form 4 filing with the SEC.

Summary

• Patrick Machado, a director of Adverum Biotechnologies, acquired stock options on June 17, 2024.
• The transactions involved the acquisition of 10,520 and 3,300 stock options with an exercise price of $7.32.
• These options vest on the earlier of June 17, 2025, or the 2025 annual meeting of stockholders, subject to accelerated vesting upon a change of control and continued service with the Issuer.
• Following the reported transactions, Machado directly owns 13,820 stock options.
• A Power of Attorney was executed on March 15, 2024, granting certain officers of Adverum Biotechnologies the authority to execute and file Forms 3, 4, and 5 on Machado's behalf.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating insider transactions. The acquisition of stock options can be viewed as a mildly positive signal, suggesting the director's confidence in the company, but it's not a strong indicator.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation in the biotechnology industry.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in the biotechnology industry.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options to align the interests of their leadership with those of shareholders.
• The vesting schedule and exercise price are typical for such grants, designed to incentivize long-term performance and retention.

Stakeholder Impact

• The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment, as it may signal confidence in the company's future prospects.

Key Dates